Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Vessel Prosthesis Implantation | 3 | 2018 | 31 | 0.860 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2020 | 25 | 0.780 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2018 | 12 | 0.770 |
Why?
|
| Marfan Syndrome | 1 | 2018 | 3 | 0.630 |
Why?
|
| Drug-Eluting Stents | 1 | 2018 | 11 | 0.620 |
Why?
|
| Suture Techniques | 1 | 2018 | 145 | 0.580 |
Why?
|
| Laser Therapy | 2 | 2006 | 13 | 0.320 |
Why?
|
| Myocardial Revascularization | 1 | 2006 | 18 | 0.260 |
Why?
|
| Coronary Disease | 1 | 2006 | 87 | 0.250 |
Why?
|
| Perioperative Care | 1 | 2006 | 56 | 0.250 |
Why?
|
| Endovascular Procedures | 2 | 2016 | 37 | 0.240 |
Why?
|
| Embolism, Air | 1 | 2023 | 9 | 0.230 |
Why?
|
| Thrombosis | 1 | 2023 | 64 | 0.210 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2021 | 13 | 0.190 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 24 | 0.190 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2020 | 11 | 0.190 |
Why?
|
| Lung Diseases | 1 | 2020 | 50 | 0.180 |
Why?
|
| Thrombelastography | 1 | 2020 | 6 | 0.180 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 16 | 0.180 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 43 | 0.170 |
Why?
|
| Hemolysis | 1 | 2018 | 8 | 0.160 |
Why?
|
| Humans | 14 | 2023 | 31059 | 0.160 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2018 | 35 | 0.160 |
Why?
|
| Heart Failure | 1 | 2021 | 223 | 0.150 |
Why?
|
| Vena Cava Filters | 1 | 2017 | 9 | 0.150 |
Why?
|
| Foreign-Body Migration | 1 | 2017 | 23 | 0.150 |
Why?
|
| Radiography, Interventional | 1 | 2017 | 30 | 0.150 |
Why?
|
| Device Removal | 1 | 2017 | 91 | 0.140 |
Why?
|
| Heart Ventricles | 1 | 2017 | 183 | 0.140 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2016 | 12 | 0.140 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 16 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2021 | 3808 | 0.130 |
Why?
|
| Stents | 1 | 2016 | 86 | 0.130 |
Why?
|
| Postoperative Complications | 3 | 2016 | 996 | 0.130 |
Why?
|
| Male | 7 | 2018 | 16488 | 0.130 |
Why?
|
| Duodenal Diseases | 1 | 2013 | 6 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2013 | 4 | 0.110 |
Why?
|
| Intestinal Fistula | 1 | 2013 | 7 | 0.110 |
Why?
|
| Abdominal Pain | 1 | 2013 | 10 | 0.110 |
Why?
|
| Polychondritis, Relapsing | 1 | 2013 | 2 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 11 | 0.110 |
Why?
|
| Adult | 5 | 2018 | 8945 | 0.100 |
Why?
|
| Middle Aged | 4 | 2018 | 10235 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2016 | 818 | 0.060 |
Why?
|
| Patient Selection | 1 | 2006 | 246 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2004 | 32 | 0.060 |
Why?
|
| Iatrogenic Disease | 1 | 2023 | 28 | 0.060 |
Why?
|
| Vidarabine | 1 | 2003 | 12 | 0.050 |
Why?
|
| Myxedema | 1 | 2003 | 2 | 0.050 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2003 | 18 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2003 | 17 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2003 | 31 | 0.050 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2003 | 45 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 139 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2006 | 334 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 271 | 0.050 |
Why?
|
| Inflammation | 1 | 2023 | 361 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2020 | 81 | 0.040 |
Why?
|
| Phlebography | 1 | 2017 | 12 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2017 | 49 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2017 | 99 | 0.040 |
Why?
|
| Aorta | 1 | 2016 | 28 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 98 | 0.030 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2013 | 11 | 0.030 |
Why?
|
| Aortography | 1 | 2013 | 10 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2016 | 220 | 0.030 |
Why?
|
| Female | 4 | 2016 | 17005 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2004 | 386 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 409 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 3664 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 10077 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2004 | 1936 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2004 | 4 | 0.010 |
Why?
|
| Shock, Cardiogenic | 1 | 2004 | 11 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2004 | 208 | 0.010 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2003 | 3 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 2003 | 15 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2003 | 9 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2003 | 39 | 0.010 |
Why?
|
| Rituximab | 1 | 2003 | 55 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2003 | 11 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 104 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 91 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 2003 | 32 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2004 | 1897 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 5196 | 0.010 |
Why?
|